Masoud Manjili, D.V.M., Ph.D.
Massey Cancer Center research program membership
Department of Microbiology and Immunology,
School of Medicine
DVM, University of Tehran, Iran (1990)
PhD, University of Sydney, Australia (1996)
1) Immunotherapy of tumor dormancy. We are identifying dormancy-specific neoantigens in order to develop personalized cancer vaccines for the prevention of distant recurrence of breast cancer. 2) Immune modulation during diet-induced progression of fatty liver disease to hepatocellular carcinoma. Using an animal model of diet-induced fatty liver disease, we are investigating the role microbiome in the regulation of the liver's immune system in order to develop immunotherapeutics for the prevention of HCC.
Disease focus of research
Breast, Prostate, Hepatic
Animal models,Autophagy,Bioinformatics,Biomarkers,Cancer cell biology,Cancer disparities,Cancer therapy,Immunotherapy,Inflammation,Obesity,Senescence,Translational science,Tumor microenvironment
Published research (during tenure as a Massey Cancer Center member)
Search In PubMed